Guides privacy audit sampling methodology including statistical and non-statistical sampling, sample size determination, stratification techniques, attribute sampling for compliance testing, confidence level selection, tolerable deviation rates, and extrapolation of results to the population. Keywords: audit sampling, statistical sampling, attribute testing, sample size, confidence level, stratified sampling, privacy audit.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
설치 방법 보기설치하기 전에 에이전트에게 전달되는 지시 내용을 확인할 수 있습니다.
Audit sampling is the application of audit procedures to less than 100% of items within a population to form a conclusion about the entire population. In privacy auditing, sampling is used to test compliance of processing activities, DSAR responses, consent records, vendor contracts, and other privacy controls without examining every individual record.
ISA 530 (International Standard on Auditing — Audit Sampling) and IIA Practice Advisory 2320-3 (Audit Sampling) provide the authoritative frameworks. For privacy audits, sampling must account for the heightened regulatory scrutiny of personal data processing and the potential for significant harm from individual non-compliant records.
| Approach | Description | When to Use |
|---|---|---|
| Statistical Sampling | Uses probability theory to select samples and evaluate results; allows quantification of sampling risk | When audit conclusions must be defensible to regulators; large populations; need to extrapolate results |
| Non-Statistical (Judgemental) Sampling | Auditor uses professional judgement to select items | Small populations; targeted testing of known risk areas; supplementary to statistical sampling |
Used to estimate the rate of deviation (non-compliance) in a population.
| Parameter | Description | Typical Privacy Audit Values |
|---|---|---|
| Population Size | Total items in the auditable population | e.g., 1,000 DSARs, 500 vendor contracts |
| Confidence Level | Probability that sample results reflect the population | 90% (standard); 95% (regulatory-facing) |
| Tolerable Deviation Rate | Maximum acceptable non-compliance rate | 5% (standard); 2% (critical controls) |
| Expected Deviation Rate | Estimated actual non-compliance rate | Based on prior audits or risk assessment |
| Sample Size | Number of items to test | Calculated from above parameters |
| Population | 90% Confidence / 5% Tolerable | 95% Confidence / 5% Tolerable | 95% Confidence / 2% Tolerable |
|---|---|---|---|
| 100 | 38 | 45 | 64 |
| 250 | 42 | 50 | 100 |
| 500 | 44 | 54 | 131 |
| 1,000 | 45 | 57 | 154 |
| 5,000 | 46 | 59 | 176 |
| 10,000+ | 46 | 59 | 181 |
Divides the population into subgroups (strata) and samples proportionally or disproportionately from each.
| Stratification Factor | Example Strata | Rationale |
|---|---|---|
| Business Unit | EU, US, APAC | Different regulatory requirements per jurisdiction |
| Data Sensitivity | Standard, sensitive, special category | Higher-risk data categories warrant more testing |
| Processing Purpose | Marketing, HR, customer service | Different compliance requirements per purpose |
| Time Period | Q1, Q2, Q3, Q4 | Detect seasonal patterns or deterioration |
| Vendor Tier | Tier 1 (high volume), Tier 2, Tier 3 | Focus sampling on highest-risk vendors |
| Method | Description | Application |
|---|---|---|
| Haphazard Selection | Items selected without structured method but avoiding bias | Quick preliminary testing |
| Block Selection | All items in a specific period or location | Testing a specific time window (e.g., all DSARs in March) |
| Judgemental Selection | Auditor selects items based on risk factors | Targeting high-value items, known exceptions, or anomalies |
| Consideration | Guidance |
|---|---|
| Individual harm threshold | Even a single non-compliant record can cause significant harm; auditors must not dismiss isolated findings |
| Regulatory expectations | Supervisory authorities may expect higher confidence levels for critical controls (breach notification, consent) |
| Special category data | Apply lower tolerable deviation rates (2%) for processing involving special category data under Article 9 |
| Automated processing | For fully automated processes, increase sample to verify algorithmic consistency across edge cases |
| Cross-border transfers | Stratify by destination country to verify adequacy/safeguard mechanism for each transfer route |
| Scenario | Sample Deviation Rate | Conclusion |
|---|---|---|
| Rate below tolerable deviation | e.g., 2% observed vs 5% tolerable | Population likely compliant; no material finding |
| Rate equals tolerable deviation | e.g., 5% observed vs 5% tolerable | Borderline; consider expanding sample or raising as medium finding |
| Rate exceeds tolerable deviation | e.g., 12% observed vs 5% tolerable | Material non-compliance; formal finding required |
| Zero deviations found | 0% observed | Strong evidence of compliance (but does not guarantee 100%) |
When sample results show deviations, the auditor must project findings to the full population:
| Element | Calculation |
|---|---|
| Point estimate | (Deviations found / Sample size) × Population size |
| Upper deviation limit | Calculated using statistical tables at the selected confidence level |
| Projected monetary impact | Point estimate × average impact per deviation |
아직 리뷰가 없습니다. 사용해 본 소감을 남겨 주세요.
로그인 없이 쓸 수 있습니다. 사용 후기, 질문, 작동하지 않은 환경 등을 편하게 남겨 주세요.
아직 댓글이 없습니다. 첫 댓글을 남겨 보세요.
Implements 42 CFR Part 2 protections for substance use disorder patient records. Covers written consent requirements stricter than HIPAA, re-disclosure prohibition, court order procedures, qualified service organization agreements, and 2024 amendments aligning Part 2 with HIPAA. Keywords: 42 CFR Part 2, substance use disorder, SUD records, re-disclosure, consent, Part 2 amendments.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Guides assessment of third-country adequacy decisions under GDPR Article 45 for international data transfers. Covers the current EC adequacy decisions list, adequacy assessment criteria, partial adequacy handling, and monitoring of adequacy decision reviews. Keywords: adequacy decision, Article 45, third country, adequate protection, EC adequacy list.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Implements age-gating mechanisms for online services to restrict access based on user age. Covers hard gates versus soft gates, neutral age prompts, re-verification triggers, circumvention prevention, and regulatory requirements under GDPR, COPPA, UK Online Safety Act, and DSA. Keywords: age gate, age restriction, neutral prompt, children, online services, access control.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Evaluates and implements age estimation and verification technologies for online services. Covers facial age estimation, digital ID verification, self-declaration with risk assessment, AI-based age estimation, and the accuracy versus privacy tradeoff. Includes ICO guidance and euCONSENT framework. Keywords: age verification, age estimation, facial analysis, digital ID, children, online safety.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Preparing EU AI Act compliance documentation for high-risk AI systems. Covers Annex III classification, technical documentation under Art. 11, conformity assessment, risk management systems, and CE marking requirements. Keywords: EU AI Act, high-risk AI, Annex III, conformity assessment, CE marking.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Implements GDPR Art. 22 automated decision-making and AI Act Art. 14 human oversight requirements for AI systems. Covers identification of solely automated decisions, meaningful human intervention design, logic explanation mechanisms, and contestation procedures. Keywords: Art. 22, automated decision, human oversight, AI Act, profiling, contestation.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.